AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

EVRAZ PLC

Report Publication Announcement Aug 2, 2019

5304_rns_2019-08-02_3a3f58e4-8a4b-429f-9059-fdca07fafe35.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7093H

Evraz Plc

02 August 2019

NOTICE OF H1 2019 RESULTS AND CONFERENCE CALL DETAILS

02 August 2019 - EVRAZ plc (LSE: EVR) will release its financial results for the six months ended 30 June 2019 on Thursday, 8 August 2019.

A conference call to discuss the results, hosted by Alexander Frolov, CEO, and Nikolay Ivanov, CFO, will be held on Thursday, 8 August 2019, at:

3 pm (London time)

5 pm (Moscow time)

10 am (New York time)

To join the call, please dial:

+44 (0)330 336 9411 UK
+7 495 646 9190 Russia
+1 929 477 0402 US

Conference ID: 6506107

To avoid any technical inconvenience, it is recommended that participants dial in 10 minutes before the start of the call.

The presentation for the call will be available on the Group's website, www.evraz.com, on Thursday, 8 August 2019, at the following link:

https://www.evraz.com/en/investors/reports-and-results/presentations/#2019

An MP3 recording will be available on Friday, 9 August 2019, at the following link:

https://www.evraz.com/en/investors/reports-and-results/presentations/#2019

For further information:

Investor Relations:

London: +44 207 832 8990        

Moscow: +7 495 232 1370

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NOREAXPAEFKNEEF

Talk to a Data Expert

Have a question? We'll get back to you promptly.